Outcomes for high-risk defining events in follicular lymphoma following frontline immunochemotherapy.
Tobin JWD, Chikatamarla VA, Matic M, Griffin A, Chowdhury R, Salvaris R, Goh A, Black H, Tong TH, Birks C, Jain S, Goodall E, Sirdesai S, Trevis T, Steinepreis E, Chen Y, Li L, Broadby G, Gutta N, Morris K, Cochrane T, Trotman J, Talaulikar D, Shortt J, Hodges G, Hawkes EA, Cheah CY, Barraclough A, Manos K, Johnston A, Royle J, Mondello P, Ansell SM, Hapgood G.
Tobin JWD, et al. Among authors: chowdhury r.
Blood Neoplasia. 2024 Oct 8;1(4):100044. doi: 10.1016/j.bneo.2024.100044. eCollection 2024 Dec.
Blood Neoplasia. 2024.
PMID: 40552131
Free PMC article.